Browsing by Author Abdurakhmanov, D

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 2 to 5 of 5 < previous 
TitleAuthor(s)Issue DateViews
 
Reduced changes in bone mineral density in Chronic HBV (CHB) Patients receiving Tenofovir Alafenamide (TAF) compared with Tenofovir Disoproxil Fumarate (TDF)
Proceeding/Conference:The Liver Meeting® 2016
Seto, WKWAsahina, YPeng, CYStanciu, CAbdurakhmanov, DFlaherty, JKim, KGaggar, ASubramanian, MTabak, FNguyen, TTChan, HLY
2016
52
 
Reduced changes in bone mineral density in chronic hepatitis B patients receiving TAF compared with TDF
Proceeding/Conference:Conference of the Asian Pacific Association for the Study of the Liver, APASL 2017
Seto, WKWAsahina, YPeng, CYStanciu, CAbdurakhmanov, DFlaherty, JKim, LGaggar, ASubramanian, MTabak, FNguyen, TTChan, HLY
2017
38
 
RETRACTION: Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV Infection
Journal:Clinical Gastroenterology and Hepatology
Seto, WKWAsahina, YBrown, TTPeng, CYStanciu, CAbdurakhmanov, DTabak, FNguyen, TTChuang, WLInokuma, TIkeda, FSantantonio, TAHabersetzer, FRamji, ALau, AHSuri, VFlaherty, JFWang, HGaggar, ASubramanian, GMMukewar, SBrunetto, MRFung, SChan, HL
2018
50
 
Safety and efficacy at 1 year after switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in chronic HBV patients with risk factors for TDF use
Proceeding/Conference:Journal of Hepatology
Gane, ESeto, WKWJanssen, HCarantu, FAKim, HJAbdurakhmanov, DNishiguchi, SAndrzej, HBae, HMo, SSuri, VGaggar, AFlaherty, JFKao, JHBrunetto, MFerret, MB
2018
101
Showing results 2 to 5 of 5 < previous